<code id='5AD55DE48A'></code><style id='5AD55DE48A'></style>
      • <acronym id='5AD55DE48A'></acronym>
      <center id='5AD55DE48A'><center id='5AD55DE48A'><tfoot id='5AD55DE48A'></tfoot></center><abbr id='5AD55DE48A'><dir id='5AD55DE48A'><tfoot id='5AD55DE48A'></tfoot><noframes id='5AD55DE48A'>
      • <optgroup id='5AD55DE48A'><strike id='5AD55DE48A'><sup id='5AD55DE48A'></sup></strike><code id='5AD55DE48A'></code></optgroup>
        5. <b id='5AD55DE48A'><label id='5AD55DE48A'><select id='5AD55DE48A'><dt id='5AD55DE48A'><span id='5AD55DE48A'></span></dt></select></label></b><u id='5AD55DE48A'></u>
          <i id='5AD55DE48A'><strike id='5AD55DE48A'><tt id='5AD55DE48A'><pre id='5AD55DE48A'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / entertainment / explore      
           
     
           
      
          explore 
           
      
           
      
           
       2025-10-02 00:14:46 
   
      
           
      
           
                        
          explore  
          
                                   
                 
                                      author：focus   
                                        
                                      
                                      Page View：7361
                                  
                                    
          
                                   
          Adam's take main illustration
          Molly Ferguson/STAT
          Biotech is awash in PIPEs.
          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.
          advertisement
          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          STAT wants to know your pick for a great summer read or listen
                                
                            
          Next article：  
                                      
                                          Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles